London-based Boltz raises $110M Series A for AI drug discovery
Tech.eu· John Reynolds·· 1 days agoTop DealsAI Score80
London-based Boltz raises $110M Series A for AI drug discovery
London-based Boltz raises $110M Series A
AI Overview
London-based AI drug discovery startup Boltz raised a $110M Series A led by Bessemer Venture Partners.
Why it matters
Boltz's $110M Series A, led by Bessemer less than a year after leaving stealth, shows how quickly open-source protein-structure models are turning into funded drug-discovery platforms.